NCT03076021View on ClinicalTrials.gov

Effects of Isotretinoin on CYP2D6 Activity

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 26, 2016

Primary Completion Date

November 27, 2023

Study Completion Date

November 27, 2023

Conditions
CYP2D6 Polymorphism
Interventions
DRUG

Isotretinoin

Drug interaction study

DRUG

dextromethorphan

Drug interaction study

Trial Locations (1)

98195

University of Washington, Seattle

All Listed Sponsors
collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

University of Washington

OTHER

NCT03076021 - Effects of Isotretinoin on CYP2D6 Activity | Biotech Hunter | Biotech Hunter